MedPath

Does muscle mass & wasting imply a poorer outcome after liver transplanatation?

Not Applicable
Conditions
Health Condition 1: K740- Hepatic fibrosis
Registration Number
CTRI/2023/06/054029
Lead Sponsor
Amrita Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with End - stage liver disease presenting for liver transplant

Exclusion Criteria

1. emergency transplant surgery

2.acute liver failure

3. patients with hepatic encephalopathy and inability to practice tests

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Correlation of frailty assessed by the liver frailty index on length of intensive care unit stay in liver recipients.Timepoint: Duration of ICU stay
Secondary Outcome Measures
NameTimeMethod
1.Correlation of liver frailty index <br/ ><br>a.Length of hospital stay <br/ ><br>b.Need for readmission to intensive care unit <br/ ><br>c.Relook surgery <br/ ><br>d.Need for intubation <br/ ><br>e.Infection <br/ ><br>f.Escalation of antibiotics <br/ ><br>2.Correlation of sarcopenia <br/ ><br>3.Assessment of nutrition using Liver Disease Undernutrition Screening Tool (LDUST) <br/ ><br>Timepoint: 1. ICU stay duration
© Copyright 2025. All Rights Reserved by MedPath